Posted by Michael Wonder on 07 Jan 2019
Drug pricing is pharma’s top concern in 2019
4 January 2019 - More than half of industry respondents say pricing will have the greatest negative impact this year.
Drug pricing and reimbursement remains at the forefront of pharma executive minds as 2019 gets underway, according to a new industry survey.
The GlobalData poll suggests more than half (51%) of industry respondents think that pricing will have the greatest negative impact on the sector this year. Pharma companies still seem to be chancing their luck however, with more than three dozen welcoming in the New Year with price hikes on around 250 medicines, according to a Reuters report.
